Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Centre for Pharmacovigilance | Statement: [Norwegian Institute of Public Health, hasPart, Centre for Pharmacovigilance]

Target entity: Centre for Pharmacovigilance
Context triple: [Norwegian Institute of Public Health, hasPart, Centre for Pharmacovigilance]

• A. Pharmacovigilance Risk Assessment Committee
  The Pharmacovigilance Risk Assessment Committee is a scientific body responsible for evaluating and monitoring the safety of human medicines and advising on risk management measures in the European Union.
• B. Center for Drug Evaluation and Research
  The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
• C. WHO Collaborating Centre for Drug Statistics Methodology
  The WHO Collaborating Centre for Drug Statistics Methodology is a specialized World Health Organization center responsible for developing and maintaining international standards for drug classification and consumption statistics, including the ATC/DDD system.
• D. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
  The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
• E. UK Medicines and Healthcare products Regulatory Agency
  The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: Centre for Pharmacovigilance
Triple: [Norwegian Institute of Public Health, hasPart, Centre for Pharmacovigilance]

The Centre for Pharmacovigilance is a Norwegian public health unit responsible for monitoring, assessing, and improving the safety of medicines and vaccines in Norway.

Target entity: Centre for Pharmacovigilance
Target entity description: The Centre for Pharmacovigilance is a Norwegian public health unit responsible for monitoring, assessing, and improving the safety of medicines and vaccines in Norway.

• A. Pharmacovigilance Risk Assessment Committee
  The Pharmacovigilance Risk Assessment Committee is a scientific body responsible for evaluating and monitoring the safety of human medicines and advising on risk management measures in the European Union.
• B. Center for Drug Evaluation and Research
  The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
• C. WHO Collaborating Centre for Drug Statistics Methodology
  The WHO Collaborating Centre for Drug Statistics Methodology is a specialized World Health Organization center responsible for developing and maintaining international standards for drug classification and consumption statistics, including the ATC/DDD system.
• D. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
  The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
• E. UK Medicines and Healthcare products Regulatory Agency
  The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
• F. None of above. chosen